HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments ...

New AI-Driven Planning Platform Designed to Unlock a New Class of Disease-Modifying Therapies for CNS Disorders MUNICH & REDWOOD CITY, Calif.--(BUSIN ...

That viral claim that your frontal lobe “isn’t fully developed until 25” turns out to be more myth than milestone. Early ...

MEDFORD, Mass.--(BUSINESS WIRE)--Myrobalan Therapeutics, a biotechnology company developing novel oral neurorestorative therapies to repair damage and restore neural function in high-unmet need ...

New findings from Karolinska Institutet reveal how the gene HNRNPU coordinates several fundamental molecular processes during ...

This publication provides an overview of central nervous system (CNS) radiotracer development, discussing different aspects and stages of development. Non-invasive neuroimaging with radiotracers can ...